Emerging therapies for neurofibromatosis type 1 with symptomatic, inoperable plexiform neurofibromas

Authors

David J. Benjamin (ORCID: https://orcid.org/0000-0002-2392-886X)

Publication Details

Journal: ESMO rare cancers.
Published: 2025-06-03
DOI: https://doi.org/10.1016/j.esmorc.2025.100016
Primary Topic: Neurofibromatosis and Schwannoma Cases
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Emerging therapies for neurofibromatosis type 1 with symptomatic, inoperable plexiform neurofibromas

David J. Benjamin

Jun 3, 2025

ESMO rare cancers.

Neurofibromatosis and Schwannoma Cases

article

Emerging therapies for neurofibromatosis type 1 with symptomatic, inoperable plexiform neurofibromas

David J. Benjamin

June 3, 2025article en

Abstract

No abstract available for this paper.

ESMO rare cancers.Vol. 3

Zero hunger

Openalex Percentile: Top 80%

Neurofibromatosis and Schwannoma Cases

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Emerging therapies for neurofibromatosis type 1 with symptomatic, inoperable plexiform neurofibromas — David J. Benjamin · ESMO rare cancers. (2025) | TGRS Research Map | TGRS